Fujian Acetron New Materials Co., Ltd.

SZSE:300706 Stock Report

Market Cap: CN¥3.4b

Fujian Acetron New Materials Past Earnings Performance

Past criteria checks 1/6

Fujian Acetron New Materials has been growing earnings at an average annual rate of 1.1%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 27.8% per year. Fujian Acetron New Materials's return on equity is 1.5%, and it has net margins of 0.7%.

Key information

1.1%

Earnings growth rate

-1.6%

EPS growth rate

Chemicals Industry Growth12.1%
Revenue growth rate27.8%
Return on equity1.5%
Net Margin0.7%
Next Earnings Update28 Apr 2025

Recent past performance updates

Weak Statutory Earnings May Not Tell The Whole Story For Fujian Acetron New Materials (SZSE:300706)

Sep 05
Weak Statutory Earnings May Not Tell The Whole Story For Fujian Acetron New Materials (SZSE:300706)

Recent updates

Does Fujian Acetron New Materials (SZSE:300706) Have A Healthy Balance Sheet?

Dec 24
Does Fujian Acetron New Materials (SZSE:300706) Have A Healthy Balance Sheet?

Fujian Acetron New Materials Co., Ltd. (SZSE:300706) Looks Just Right With A 42% Price Jump

Oct 14
Fujian Acetron New Materials Co., Ltd. (SZSE:300706) Looks Just Right With A 42% Price Jump

Be Wary Of Fujian Acetron New Materials (SZSE:300706) And Its Returns On Capital

Sep 30
Be Wary Of Fujian Acetron New Materials (SZSE:300706) And Its Returns On Capital

Weak Statutory Earnings May Not Tell The Whole Story For Fujian Acetron New Materials (SZSE:300706)

Sep 05
Weak Statutory Earnings May Not Tell The Whole Story For Fujian Acetron New Materials (SZSE:300706)

Fujian Acetron New Materials Co., Ltd.'s (SZSE:300706) 30% Share Price Surge Not Quite Adding Up

Mar 06
Fujian Acetron New Materials Co., Ltd.'s (SZSE:300706) 30% Share Price Surge Not Quite Adding Up

Revenue & Expenses Breakdown

How Fujian Acetron New Materials makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:300706 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,18985527
30 Jun 241,09195727
31 Mar 241,018125729
31 Dec 23958125728
30 Sep 23896125727
30 Jun 23811105426
31 Mar 2372655126
01 Jan 23695144726
30 Sep 22679224624
30 Jun 22705244926
31 Mar 22691224725
01 Jan 22610184424
30 Sep 21550153825
30 Jun 21470153423
31 Mar 2139993423
31 Dec 2035463419
30 Sep 2030843120
30 Jun 2028333017
31 Mar 20314122715
31 Dec 19317152615
30 Sep 19320152711
30 Jun 19302182310
31 Mar 19256162111
31 Dec 18256282011
30 Sep 18240332310
30 Jun 18237381517
31 Mar 18238442013
31 Dec 17236412211
30 Sep 1722945208
31 Dec 1617536250
31 Dec 1512426160
31 Dec 148316140

Quality Earnings: 300706 has a large one-off gain of CN¥7.1M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: 300706's current net profit margins (0.7%) are lower than last year (1.3%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300706's earnings have grown by 1.1% per year over the past 5 years.

Accelerating Growth: 300706's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 300706 had negative earnings growth (-28.6%) over the past year, making it difficult to compare to the Chemicals industry average (-4.7%).


Return on Equity

High ROE: 300706's Return on Equity (1.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 05:24
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Fujian Acetron New Materials Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gen HeEverbright Securities Co. Ltd.
Zhiqiang RenIndustrial Securities Co. Ltd.